Relationship of OCT-defined plaque characteristics with CCTA-derived coronary inflammation and CMR-derived global coronary flow reserve in patients with acute coronary syndrome.
Humans
Coronary Vessels
/ diagnostic imaging
Computed Tomography Angiography
/ methods
Acute Coronary Syndrome
/ diagnostic imaging
Tomography, Optical Coherence
Retrospective Studies
Percutaneous Coronary Intervention
Coronary Angiography
/ methods
Plaque, Atherosclerotic
/ diagnostic imaging
Inflammation
/ diagnostic imaging
Magnetic Resonance Imaging
Coronary Artery Disease
/ diagnostic imaging
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2023
2023
Historique:
received:
05
12
2022
accepted:
10
05
2023
medline:
29
5
2023
pubmed:
25
5
2023
entrez:
25
5
2023
Statut:
epublish
Résumé
The relationship of layered plaque detected by optical coherence tomography (OCT) with coronary inflammation and coronary flow reserve (CFR) remains elusive. We aimed to investigate the association of OCT-defined layered plaque with pericoronary adipose tissue (PCAT) inflammation assessed by coronary computed tomography angiography (CCTA) and global (G)-CFR assessed by cardiac magnetic resonance imaging (CMR) in patients with acute coronary syndrome (ACS). We retrospectively investigated 88 patients with first ACS who underwent preprocedural CCTA, OCT imaging of the culprit lesion prior to primary/urgent percutaneous coronary intervention (PCI), and postprocedural CMR. All patients were divided into two groups according to the presence and absence of OCT-defined layered plaque at the culprit lesion. Coronary inflammation was assessed by the mean value of PCAT attenuation (-190 to -30 HU) of the three major coronary vessels. G-CFR was obtained by quantifying absolute coronary sinus flow at rest and during maximum hyperemia. CCTA and CMR findings were compared between the groups. In a total of 88 patients, layered plaque was detected in 51 patients (58.0%). The patients with layered plaque had higher three-vessel-PCAT attenuation value (-68.58 ± 6.41 vs. -71.60 ± 5.21 HU, P = 0.021) and culprit vessel-PCAT attenuation value (-67.69 ± 7.76 vs. -72.07 ± 6.57 HU, P = 0.007) than those with non-layered plaque. The patients with layered plaque had lower G-CFR value (median, 2.26 [interquartile range, 1.78, 2.89] vs. 3.06 [2.41, 3.90], P = 0.003) than those with non-layered plaque. The presence of OCT-defined layered plaque at the culprit lesion was associated with high PCAT attenuation and low G-CFR after primary/urgent PCI in patients with ACS. OCT assessment of culprit plaque morphology and detection of layered plaque may help identify increased pericoronary inflammation and impaired CFR, potentially providing the risk stratification in patients with ACS and residual microvascular dysfunction after PCI.
Sections du résumé
BACKGROUND
The relationship of layered plaque detected by optical coherence tomography (OCT) with coronary inflammation and coronary flow reserve (CFR) remains elusive. We aimed to investigate the association of OCT-defined layered plaque with pericoronary adipose tissue (PCAT) inflammation assessed by coronary computed tomography angiography (CCTA) and global (G)-CFR assessed by cardiac magnetic resonance imaging (CMR) in patients with acute coronary syndrome (ACS).
METHODS
We retrospectively investigated 88 patients with first ACS who underwent preprocedural CCTA, OCT imaging of the culprit lesion prior to primary/urgent percutaneous coronary intervention (PCI), and postprocedural CMR. All patients were divided into two groups according to the presence and absence of OCT-defined layered plaque at the culprit lesion. Coronary inflammation was assessed by the mean value of PCAT attenuation (-190 to -30 HU) of the three major coronary vessels. G-CFR was obtained by quantifying absolute coronary sinus flow at rest and during maximum hyperemia. CCTA and CMR findings were compared between the groups.
RESULTS
In a total of 88 patients, layered plaque was detected in 51 patients (58.0%). The patients with layered plaque had higher three-vessel-PCAT attenuation value (-68.58 ± 6.41 vs. -71.60 ± 5.21 HU, P = 0.021) and culprit vessel-PCAT attenuation value (-67.69 ± 7.76 vs. -72.07 ± 6.57 HU, P = 0.007) than those with non-layered plaque. The patients with layered plaque had lower G-CFR value (median, 2.26 [interquartile range, 1.78, 2.89] vs. 3.06 [2.41, 3.90], P = 0.003) than those with non-layered plaque.
CONCLUSIONS
The presence of OCT-defined layered plaque at the culprit lesion was associated with high PCAT attenuation and low G-CFR after primary/urgent PCI in patients with ACS. OCT assessment of culprit plaque morphology and detection of layered plaque may help identify increased pericoronary inflammation and impaired CFR, potentially providing the risk stratification in patients with ACS and residual microvascular dysfunction after PCI.
Identifiants
pubmed: 37228044
doi: 10.1371/journal.pone.0286196
pii: PONE-D-22-31920
pmc: PMC10212089
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0286196Informations de copyright
Copyright: © 2023 Sugiyama et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
J Thromb Thrombolysis. 2020 Nov;50(4):886-894
pubmed: 32306291
Atherosclerosis. 2020 Sep;309:1-7
pubmed: 32836017
J Cardiol. 2018 Apr;71(4):359-366
pubmed: 29103734
J Am Coll Cardiol. 2012 Mar 20;59(12):1058-72
pubmed: 22421299
Circulation. 2006 Jun 13;113(23):2733-43
pubmed: 16754804
Atherosclerosis. 2018 Aug;275:35-42
pubmed: 29859471
J Am Coll Cardiol. 2019 May 14;73(18):2253-2263
pubmed: 31072568
JAMA Cardiol. 2019 Apr 1;4(4):321-329
pubmed: 30865212
JAMA Cardiol. 2018 Sep 1;3(9):858-863
pubmed: 30027285
Circulation. 2017 Dec 12;136(24):2325-2336
pubmed: 28864442
J Am Heart Assoc. 2022 Mar;11(5):e023519
pubmed: 35179042
Eur Heart J. 2011 May;32(10):1251-9
pubmed: 21273202
Lancet. 2018 Sep 15;392(10151):929-939
pubmed: 30170852
Circulation. 2001 Feb 20;103(7):934-40
pubmed: 11181466
Heart. 1999 Sep;82(3):265-8
pubmed: 10455072
Int J Cardiol. 2021 Jun 15;333:226-232
pubmed: 33741428
J Cardiovasc Magn Reson. 2020 Oct 8;22(1):73
pubmed: 33028350
Circulation. 2008 Sep 2;118(10):1011-20
pubmed: 18725488
JACC Cardiovasc Imaging. 2013 Jun;6(6):668-71
pubmed: 23764095
JACC Cardiovasc Imaging. 2022 Oct;15(10):1830-1832
pubmed: 36202463
JACC Cardiovasc Interv. 2018 Oct 22;11(20):2058-2068
pubmed: 30336810
Eur Heart J Cardiovasc Imaging. 2018 Jan 1;19(1):108-116
pubmed: 28950314
J Am Coll Cardiol. 2020 Feb 11;75(5):453-463
pubmed: 32029126
J Am Heart Assoc. 2020 Aug 4;9(15):e016202
pubmed: 32750306
Circ Cardiovasc Imaging. 2017 Sep;10(9):
pubmed: 28893795
Circulation. 2000 Jun 13;101(23):2696-702
pubmed: 10851206
Eur Heart J. 2010 Feb;31(4):401-15
pubmed: 19892716
Atherosclerosis. 2015 Mar;239(1):260-7
pubmed: 25634157
JACC Cardiovasc Imaging. 2022 May;15(5):828-839
pubmed: 34876381
Sci Rep. 2021 Sep 24;11(1):19026
pubmed: 34561466
Arterioscler Thromb Vasc Biol. 2020 Jun;40(6):1587-1597
pubmed: 32295419
JAMA. 2012 Sep 5;308(9):890-6
pubmed: 22948699
J Thromb Thrombolysis. 2020 Nov;50(4):895-902
pubmed: 32399759
JACC Cardiovasc Imaging. 2018 Dec;11(12):1773-1781
pubmed: 29680352